On April 12, 2021, Senator Kolkhorst, along with a bipartisan group of cosponsors, introduced SB 2195, a Bill that prohibits Pharmacy Benefit Managers (“PBMs”) operating in Texas from assessing against pharmacies a variety of different types of... Read More
Blogs & Articles | Community, Retail Pharmacies | DIR Fees | Life Sciences | Payor Network Access and Defense of Network Terminations | Pharmacy Law

In Wisconsin, Governor Tony Evers recently signed a bipartisan bill into law aimed at regulating pharmacy benefit managers (PBMs). This law, which was unanimously passed in the Wisconsin legislature, is significant for several reasons including... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | DIR Fees | Life Sciences | Pharmacy Law

The specialty pharmacy space has proven to be a rewarding investment for private equity, as specialty medications typically lead the pharmacy trend cost curve, which will only continue as more than 60 new specialty medications expected to receive... Read More
Blogs & Articles | COVID-19 Resources | DIR Fees | Life Sciences | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies | Specialty Pharmacies

Has your pharmacy or dispensing practice recently received a remittance that included large “submission fees,” sometimes designated with the code “AH:444,” without explanation?  Frier Levitt has learned those fees are DIR fees being charged... Read More
Blogs & Articles | Community, Retail Pharmacies | DIR Fees | Life Sciences | Pharmacy Law

Ohio legislators have introduced bipartisan Senate and House bills aimed at curbing excessive fees charged by insurers and Pharmacy Benefit Managers to pharmacies and providers participating in the 340B Drug Pricing Program. The 340B Program,... Read More
Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law | Section 340B In-House and Contract Pharmacies